FindTrial
Sign In

A Randomized Double-blind Controlled Study of Tiaoqi Daozhi Formula Granules in the Treatment of Irritable Bowel Syndrome with Predominant Constipation(Syndrome of Qi Stagnation due to Liver Depression)

Clinical Quantitative Efficacy Study on the Treatment of Irritable Bowel Syndrome with Predominant Constipation by Tiaoqi Daozhi Decoction Formula Granules

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000592
Enrollment
Unknown
Registered
2024-10-21
Start date
2024-11-15
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome with Predominant Constipation

Interventions

None listed

Sponsors

Chongqing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the medical diagnostic criteria of IBS-C; (2) Meet the diagnostic criteria of Chinese medicine evidence; (3) Average weekly pain score >=3 (NRS scale) (4) Exclusion of related organic diseases by colonoscopy within 1 year; (5) Age 18-65 years old, gender is not limited; (6) Volunteer and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe underlying diseases; (2) Those with organic diseases of the intestinal tract confirmed by colonoscopy and other diseases that can affect the function of intestinal motility; (3) Women in pregnancy; (4) People with severe allergies; (5) Those who have participated in other clinical trials; (6) Those who are taking other medications and are unable to stop eluting for more than 2 weeks.

Design outcomes

Primary

MeasureTime frame
;;;—

Contacts

Public Contactxiaojun yang

Chongqing Hospital of Traditional Chinese Medicine

yangxj88@126.com+86 13290007489

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026